Treace Medical Concepts, Inc. (TMCI) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | 7.23M | -8.03M | -9.09M | -3.05M | 4.2M | -4.21M | -11.84M | -13.9M | -7.22M | 532K | -9.51M | -8.34M |
| Operating CF Margin % | 15.33% | -12.84% | -18.11% | -6.44% | 7.99% | -6.12% | -26.27% | -31.26% | -14.13% | 0.86% | -23.34% | -19.87% |
| Operating CF Growth % | 72.32% | -90.78% | 23.22% | 78.05% | 158.14% | -890.79% | -24.48% | -66.73% | 58.16% | 109.93% | -27.13% | 21.11% |
| Net Income | -17.96M | -9.39M | -16.29M | -17.4M | -15.92M | -501K | -15.36M | -21.21M | -18.68M | -6.28M | -17.52M | -12.27M |
| Depreciation & Amortization | 899K | 2.88M | 2.85M | 2.46M | 2.46M | 2.24M | 2.16M | 2.12M | 1.91M | 1.77M | 1.56M | 1.17M |
| Stock-Based Compensation | 0 | 7.55M | 8M | 9.58M | 8.69M | 8.55M | 7.9M | 6.74M | 7.41M | 5.87M | 5.19M | 3.6M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -19.61M | -367K | 0 |
| Other Non-Cash Items | 9.56M | 4.04M | -2.84M | 819K | 1.26M | 2.51M | -539K | 2.43M | 581K | 20.3M | 838K | 3.41M |
| Working Capital Changes | 14.73M | -13.11M | -812K | 1.49M | 7.7M | -17.01M | -6M | -3.98M | 1.56M | -1.52M | 781K | -4.24M |
| Change in Receivables | 11.69M | -9.52M | -2.56M | 696K | 9.29M | -17.19M | 1.21M | 2.48M | 7.82M | -13.42M | 2.23M | -1.91M |
| Change in Inventory | -335K | 5.39M | 973K | -4.46M | 1.31M | 4.36M | -2.33M | -5.42M | -6.62M | 67K | -3.21M | -3.52M |
| Change in Payables | 6.81M | -9.38M | 0 | 6.74M | 2.7M | -8.13M | 576K | -3.08M | 9.31M | 3.15M | 534K | 0 |
| Cash from Investing | -7.82M | 9.67M | 8.74M | -3.26M | -1.89M | 3.42M | 5.76M | 22.43M | 3.76M | 5.01M | 4.6M | -10.42M |
| Capital Expenditures | -3.06M | -2.4M | -2.81M | -4.77M | -3.54M | -3.07M | -2.86M | -1.73M | -3.93M | -2.25M | -3.5M | -4.23M |
| CapEx % of Revenue | 6.49% | 3.84% | 5.59% | 10.06% | 6.74% | 4.47% | 6.35% | 3.89% | 7.68% | 3.61% | 8.59% | 10.09% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -7.25M | -8.1M | -20M |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 11.54M | 0 | 0 | 0 | 0 | 0 | 0 | 7.25M | 8.1M | 13.81M |
| Cash from Financing | -582K | 1.38M | -10K | 987K | -282K | 26K | 8K | 311K | -185K | 165K | 159K | 1.18M |
| Debt Issued (Net) | -466K | 1.39M | 0 | 885K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 91K | 70K | -412K | 116K | 119K | 57K | 8K | 311K | 52K | 178K | 159K | -6.32M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | -412K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6.32M |
| Other Financing | -207K | -75K | 402K | -14K | -401K | -31K | 0 | 0 | -237K | -13K | 0 | 7.5M |
| Net Change in Cash | -1.16M | 3.02M | -366K | -5.32M | 2.02M | -760K | -6.07M | 8.85M | -3.65M | 5.7M | -4.76M | -17.58M |
| Free Cash Flow | 4.17M | -10.42M | -11.9M | -7.82M | 655K | -7.28M | -14.71M | -15.63M | -11.15M | -1.72M | -13.01M | -12.57M |
| FCF Margin % | 8.84% | -16.67% | -23.7% | -16.5% | 1.25% | -10.6% | -32.62% | -35.15% | -21.81% | -2.76% | -31.93% | -29.95% |
| FCF Growth % | 536.95% | -43.17% | 19.07% | 49.97% | 105.88% | -324.3% | -12.99% | -24.35% | 40.5% | 77.69% | 2.44% | 20.13% |
| FCF per Share | 0.06 | -0.16 | -0.19 | -0.12 | 0.01 | -0.12 | -0.24 | -0.25 | -0.18 | -0.03 | -0.21 | -0.20 |
| FCF Conversion (FCF/Net Income) | -0.40x | 0.85x | 0.56x | 0.18x | -0.26x | 8.40x | 0.77x | 0.66x | 0.39x | -0.08x | 0.54x | 0.68x |
| Interest Paid | 0 | 0 | 1.26M | 0 | 1.23M | 0 | 0 | 0 | 0 | 0 | 0 | 1.28M |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |